Established 1999
123jump.com - U.S. Financial Information Archive: 90,000 Annual and 10-K reports – 20,000 Global news stories - 3,500 IPO reports - 1,700 - Earnings Calls – 320 Fund Interviews – 10-year Annual earnings on 4,500 stocks – 20 Quarterly earnings on 3,600 stocks – 1,800 IPO prospectuses – 1,200 Economic data releases
     
   
 

Genometrix Inc.(GNMX)

 
123Jump Rating:   Underwriters: Lehman Brothers
      Chase H & Q
Status:   Dain Rauscher Wessels
 
Address: 2700 Researach Forest Drive
 FiledDate:
     
  Filed Price Range ($):
       
Telephone: (281) 465-5000 Filed Offer Amount ($ Million): $0.00
       
Fax: Shares Offered (Millions): 7,000,000
       
Websites: Shares Outstanding (Millions): 30,068,437
       
Management: Mitchel D. Eggers, Chairman/CEO/Dir.
 IPO Date:
  Robert H. Ellis, President
    
  David E. Jorden, VP/CFO
 Final Offer Price ($): $0.00
       
Industry: Final Offer Size (Millions of Shares): 0.00
       
Employees: 106 Final Offer Amount ($ Million): $0.00
       
Competitors: Incyte Pharmaceuticals
 S-1 Forms:
  Orchard Biosciences
    
  PE Biosystems
  
       
     
     
     
       
 
- Avoid        - Value Gap        - Short-Term Growth        - Long-Term Growth        - Long-Term Value

Income Data 
Year Revenues Costs Oper Income Taxes Net Income EPS
1995 714 1063 -349 0.00 -394 -.04
1996 796 1419 -623 0.00 -689 -.07
1997 1004.26 1168.29 -164.02 0.00 -303.86 -.03
1998 1544.04 2846.66 -1302.62 0.00 -1714.65 -.16
1999 1651.14 6117.05 -4465.9 0.00 -4370 -.39
2000 1283.75 10628.89 -9345.14 0.00 -9226.11 -1.06
* Six Months ended March 31, 2000
 
 
© 1999-2008 123jump.com. All rights reserved